As of January 2023, our "Journal of Controversies Obstetrics & Gynecology and Pediatrics" has been published under the Medihealth Academy to publish all articles, reviews and case reports on Pediatrics, especially in the field of Obstetrics and Gynecology. In order to facilitate the citation of the articles, to take our place in internationally respected indexes and to reach a wider readership, we will pay attention to the fact that our article language is only English in terms of acceptance. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

EndNote Style
Original Article
A study on the factors affecting polycystic ovary syndrome in young women
Aims: The aim of this study was to define the incidence of polycystic ovary syndrome (PCOS) in young women and the affecting characteristics. In this study, environmental factors and demographic characteristics of women with PCOS were compared with the control group, which included healthy young women.
Methods: This is a retrospective study with control in young women aged 18-25, suffering from PCOS and healthy women, referred to our clinic between September 2018- August 2020. Women's socio-demographic characteristics such as age, weight, height, economic status, employment status, education status, smoking and alcohol abuse, chronic disease, exercise status, family history of cancer, and menstrual irregularity of participants were compared.
Results: Results did not show a statistically significant association between case and control regarding age, economic status, education status, family history of cancer, smoking and alcohol abuse (p>0.05). There was a statistically significant difference between groups regarding menstrual irregularity, chronic disease, body mass index (BMI), exercise and working status (p<0.05). Healthy women exercise more, and a higher percentage of them are employed. Chronic diseases were more common in women with PCOS. Women with PCOS were fatter and had more menstrual irregularities problems.
Conclusion: BMI, working status, exercise status, menstrual irregularity, and chronic disease status helped diagnose PCOS in young women.

1. G&uuml;rb&uuml;z T, Alanya Tosun S, Cebi A, G&ouml;kmen O, Usta M. Investigatingfetuin-a and paraoxonase-1 activity as markers in polycystic ovarysyndrome based on body mass index: a prospective case-control study.Cureus. 2021;13(10):e18553. doi:10.7759/cureus.18553
2. Gleicher N, Darmon S, Patrizio P, Barad DH. Reconsidering thepolycystic ovary syndrome (PCOS). Biomedicines. 2022;10(7):1505.doi:10.3390/biomedicines10071505
3. Chaudhuri A. Polycystic ovary syndrome: causes, symptoms,pathophysiology, and remedies. Obesity Medicine. 2023:100480.https://doi.org/10.1016/j.obmed.2023.100480
4. Alanya Tosun Ş, G&uuml;rb&uuml;z T, Cebi A, Tosun A, G&ouml;kmen O, Usta M.Association of increased levels of omentin-1 and carotid intima-mediathickness with early signs of cardiovascular risk in patients withpolycystic ovary syndrome: a prospective case control study. J ObstetGynaecol Res. 2022;48(1):169-177. doi:10.1111/jog.15077
5. Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, StroopDM, Wang P. Obesity, free testosterone, and cardiovascular riskfactors in adolescents with polycystic ovary syndrome and regularlycycling adolescents. Metabolism. 2006;55(4):508-514. doi:10.1016/j.metabol.2005.11.003
6. G&uuml;rb&uuml;z T, G&ouml;kmen O, G&uuml;ng&ouml;r ND. Polikistik over sendromu bulunankadınlarda glikoz potasyum oranının tanısal değerinin ins&uuml;lin ilekarşılaştırılması. &Ccedil;ukurova Med J. 2021;46(1):381-386. doi:10.17826/cumj.782931
7. Zhu T, Cui J, Goodarzi MO. Polycystic ovary syndrome and risk of type2 diabetes, coronary heart disease, and stroke. Diabetes. 2021;70(2):627-637. doi:10.2337/db20-0800
8. G&uuml;rb&uuml;z T, G&ouml;kmen O, Ayar Madenli A, Dilbaz B. R-Spondin1 andtumor necrosis factor-alpha in infertile women with polycystic ovarysyndrome: relationships with insulin resistance and other parameters. JHealth Sci Med. 2023;6(2):449-455.
9. Jiskoot G, Somers S, De Roo C, Stoop D, Laven J. Translation of the modifiedpolycystic ovary syndrome questionnaire (mPCOSQ) and the polycysticovary syndrome quality of life tool (PCOSQOL) in dutch and flemish womenwith PCOS. J Clin Med. 2023;12(12):3927. doi:10.3390/jcm12123927
10. Deans R. Polycystic ovary syndrome in adolescence. Med Sci (Basel).2019;7(10):101. doi:10.3390/medsci7100101
11. Welt CK, Duran JM. Genetics of polycystic ovary syndrome. SeminReprod Med. 2014;32(3):177-182. doi:10.1055/s-0034-1371089
12. Urbanek M. The genetics of the polycystic ovary syndrome. Nat ClinPract Endocrinol Metab. 2007;3(2):103-111. doi:10.1038/ncpendmet0400
13. Kang H. Sample size determination and power analysis using theG*Power software. J Educ Eval Health Prof. 2021;18:17. doi:10.3352/jeehp.2021.18.17
14. Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovarysyndrome [published correction appears in lancet diabetes endocrinol.Lancet Diabetes Endocrinol. 2022;10(9):668-680. doi:10.1016/S2213-8587(22)00163-2
15. Barber TM, Franks S. Obesity and polycystic ovary syndrome. ClinEndocrinol (Oxf). 2021;95(4):531-541. doi:10.1111/cen.14421
16. Ayar Madenli A, &Ouml;z İ , G&uuml;rb&uuml;z T. The relationship between antimullerian hormone level and endometrial polyp frequency in patientswith polycystic ovary syndrome. J Med Palliat Care. 2022;3(3):263-267.https://doi.org/10.47582/jompac.1148111
17. Barkade GD, Bhongal SA, Dani PK, Gund SR. A systematic review:polycystic ovarian syndrome (PCOS). Asian J Res Pharmaceutical Sci.2022;12(4):309-313. doi:10.52711/2231-5659.2022.00053
18. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment ofcardiovascular risk and prevention of cardiovascular disease in womenwith the polycystic ovary syndrome: a consensus statement by theandrogen excess and polycystic ovary syndrome (AE-PCOS) society. JClin Endocrinol Metab. 2010;95(5):2038-2049. doi:10.1210/jc.2009-2724
19. Wang ET, Calderon-Margalit R, Cedars MI, et al. Polycystic ovarysyndrome and risk for long-term diabetes and dyslipidemia. ObstetGynecol. 2011;117(1):6-13. doi:10.1097/AOG.0b013e31820209bb
20. Palm-Fischbacher S, Ehlert U. Dispositional resilience as a moderatorof the relationship between chronic stress and irregular menstrualcycle. J Psychosom Obstet Gynaecol. 2014;35(2):42-50. doi:10.3109/0167482X.2014.912209
21. Nohara M, Momoeda M, Kubota T, Nakabayashi M. Menstrual cycleand menstrual pain problems and related risk factors among Japanesefemale workers. Ind Health. 2011;49(2):228-234. doi:10.2486/indhealth.ms1047
22. Harrison CL, Lombard CB, Moran LJ, Teede HJ. Exercise therapy inpolycystic ovary syndrome: a systematic review. Hum Reprod Update.2011;17(2):171-183. doi:10.1093/humupd/dmq045
23. Butt MS, Saleem J, Zakar R, Aiman S, Khan MZ, Fischer F. Benefitsof physical activity on reproductive health functions among polycysticovarian syndrome women: a systematic review. BMC Public Health.2023;23(1):882. doi:10.1186/s12889-023-15730-8
24. Breyley-Smith A, Mousa A, Teede HJ, Johnson NA, Sabag A. The effectof exercise on cardiometabolic risk factors in women with polycysticovary syndrome: a systematic review and meta-analysis. Int J EnvironRes Public Health. 2022;19(3):1386. doi:10.3390/ijerph19031386
25. Shahid R, Iahtisham-Ul-Haq, Mahnoor, et al. Diet and lifestylemodifications for effective management of polycystic ovarian syndrome(PCOS). J Food Biochem. 2022;46(7):e14117. doi:10.1111/jfbc.14117
Volume 1, Issue 4, 2023
Page : 95-98